Research
Membrane-confined self-assembly enables localized bioorthogonal prodrug activation and selective cancer therapy
Science · By Wenjie Wang, Jiaxin Guo, Hong Han, Dan Yuan & Junfeng Shi ·
The Brief
- A Science Advances paper, 'Membrane-confined self-assembly enables localized bioorthogonal prodrug activation and selective cancer therapy', was published in Volume 12, Issue 47 in November 2026.
- The work describes membrane-confined self-assembly as a way to achieve localized bioorthogonal prodrug activation.
- The stated goal is selective cancer therapy.
Why it matters
The approach aims to confine prodrug activation to a specific location, which could help limit drug effects on healthy tissue. Science readers in chemical biology and cancer drug development may find the method relevant.
Who’s affected
- chemical biologists
- cancer drug researchers
- #prodrug activation
- #bioorthogonal chemistry
- #cancer therapy
- #self-assembly
- #drug delivery
Science Advances, Volume 12, Issue 47 , November 2026.